Tiagabine hydrochloride

General description Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards Application

A sulfonyl hydrazide that inhibits BCATc (IC₅₀s = 0.81 and 0.

ChromegaChiral CCS (amylose tris [(S)-a-methylbenzylcarbamate]) permits the enantiomeric separation of 1-Indanol without the addition of DEA (Diethyl amine). Historically DEA has been commonly used to improve peak shape for chiral separations of

ChromegaChiral CCS (amylose tris [(S)-a-methylbenzylcarbamate]) permits the enantiomeric separation of 1-Indanol without the addition of DEA (Diethyl amine). Historically DEA has been commonly used to improve peak shape for chiral separations of

ChromegaChiral CCS (amylose tris [(S)-a-methylbenzylcarbamate]) permits the enantiomeric separation of 1-Indanol without the addition of DEA (Diethyl amine). Historically DEA has been commonly used to improve peak shape for chiral separations of

ChromegaChiral CCS (amylose tris [(S)-a-methylbenzylcarbamate]) permits the enantiomeric separation of 1-Indanol without the addition of DEA (Diethyl amine). Historically DEA has been commonly used to improve peak shape for chiral separations of

ChromegaChiral CCS (amylose tris [(S)-a-methylbenzylcarbamate]) permits the enantiomeric separation of 1-Indanol without the addition of DEA (Diethyl amine). Historically DEA has been commonly used to improve peak shape for chiral separations of

ChromegaChiral CCS (amylose tris [(S)-a-methylbenzylcarbamate]) permits the enantiomeric separation of 1-Indanol without the addition of DEA (Diethyl amine). Historically DEA has been commonly used to improve peak shape for chiral separations of

ChromegaChiral CCS (amylose tris [(S)-a-methylbenzylcarbamate]) permits the enantiomeric separation of 1-Indanol without the addition of DEA (Diethyl amine). Historically DEA has been commonly used to improve peak shape for chiral separations of

ChromegaChiral CCS (amylose tris [(S)-a-methylbenzylcarbamate]) permits the enantiomeric separation of 1-Indanol without the addition of DEA (Diethyl amine). Historically DEA has been commonly used to improve peak shape for chiral separations of

ChromegaChiral CCS (amylose tris [(S)-a-methylbenzylcarbamate]) permits the enantiomeric separation of 1-Indanol without the addition of DEA (Diethyl amine). Historically DEA has been commonly used to improve peak shape for chiral separations of

ChromegaChiral CCS (amylose tris [(S)-a-methylbenzylcarbamate]) permits the enantiomeric separation of 1-Indanol without the addition of DEA (Diethyl amine). Historically DEA has been commonly used to improve peak shape for chiral separations of